These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2186640)
1. Cerebrovascular transport of [125I]quinuclidinyl benzilate, [3H]cyclofoxy, and [14C]iodoantipyrine. Sawada Y; Hiraga S; Patlak CS; Ito K; Pettigrew KD; Blasberg RG Am J Physiol; 1990 May; 258(5 Pt 2):H1585-98. PubMed ID: 2186640 [TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of 3-quinuclidinyl 4-[125I]iodobenzilate transport and specific binding to muscarinic acetylcholine receptor in rat brain in vivo: implications for human studies. Sawada Y; Hiraga S; Francis B; Patlak C; Pettigrew K; Ito K; Owens E; Gibson R; Reba R; Eckelman W J Cereb Blood Flow Metab; 1990 Nov; 10(6):781-807. PubMed ID: 2134838 [TBL] [Abstract][Full Text] [Related]
3. BBB transport and rapid tissue binding of cyclofoxy: comparison of active and inactive enantiomers. Kawai R; Sawada Y; Channing M; Newman AH; Rice KC; Blasberg RG Am J Physiol; 1990 Oct; 259(4 Pt 2):H1278-87. PubMed ID: 2221131 [TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of cerebrovascular transport based on indicator diffusion technique. Sawada Y; Patlak CS; Blasberg RG Am J Physiol; 1989 Mar; 256(3 Pt 2):H794-812. PubMed ID: 2646954 [TBL] [Abstract][Full Text] [Related]
5. Use of [3H]methylglucose and [14C]iodoantipyrine to determine kinetic parameters of glucose transport in rat brain. Mori K; Maeda M Am J Physiol; 1997 Jan; 272(1 Pt 2):R163-71. PubMed ID: 9039005 [TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of transport and opioid receptor binding of [3H](-)-cyclofoxy in rat brain in vivo: implications for human studies. Sawada Y; Kawai R; McManaway M; Otsuki H; Rice KC; Patlak CS; Blasberg RG J Cereb Blood Flow Metab; 1991 Mar; 11(2):183-203. PubMed ID: 1847702 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype composition. Boulay SF; Gitler MS; Sood VK; Cohen VI; Zeeberg BR; Reba RC Receptor; 1995; 5(4):207-18. PubMed ID: 8840399 [TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of muscarinic receptors in human brain and salivary gland in vivo. Hiramatsu Y; Eckelman WC; Carrasquillo JA; Miletich RS; Valdez IH; Kurrasch RH; Macynski AA; Paik CH; Neumann RD; Baum BJ Am J Physiol; 1995 Jun; 268(6 Pt 2):R1491-9. PubMed ID: 7611526 [TBL] [Abstract][Full Text] [Related]
9. In vivo autoradiographic competition studies of isomers of [125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNB. Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Knapp FF Recept Signal Transduct; 1997; 7(1):45-54. PubMed ID: 9285530 [TBL] [Abstract][Full Text] [Related]
10. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Luthin GR; Wolfe BB Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291 [TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers. Kawai R; Sawada Y; Channing M; Dunn B; Newman AH; Rice KC; Blasberg RG J Pharmacol Exp Ther; 1990 Nov; 255(2):826-35. PubMed ID: 2173760 [TBL] [Abstract][Full Text] [Related]
12. The characteristics of I-125 4-IQNB and H-3 QNB in vivo and in vitro. Gibson RE; Weckstein DJ; Jagoda EM; Rzeszotarski WJ; Reba RC; Eckelman WC J Nucl Med; 1984 Feb; 25(2):214-22. PubMed ID: 6726431 [TBL] [Abstract][Full Text] [Related]
13. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit. Gibson RE; Eckelman WC; Vieras F; Reba RC J Nucl Med; 1979 Aug; 20(8):865-70. PubMed ID: 541735 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary distribution of iodoantipyrine: temperature and lipid solubility effects. Chinard FP; Basset G; Cua WO; Saumon G; Bouchonnet F; Garrick RA; Bower V Am J Physiol; 1997 May; 272(5 Pt 2):H2250-63. PubMed ID: 9176293 [TBL] [Abstract][Full Text] [Related]
15. Specific binding component of the "inactive" stereoisomer (S,S)-[125I] IQNB to rat brain muscarinic receptors in vivo. Boulay SF; McRee RC; Cohen VI; Sood VK; Zeeberg BR; Reba RC Nucl Med Biol; 1996 Apr; 23(3):211-9. PubMed ID: 8782228 [TBL] [Abstract][Full Text] [Related]
16. In vivo autoradiography of radioiodinated (R)-3-quinuclidinyl (S)-4-iodobenzilate [(R, S)-IQNB] and (R)-3-quinuclidinyl (R)-4-iodobenzilate [(R,R)-IQNB]. Comparison of the radiolabelled products of a novel tributylstannyl precursor with those of the established triazene and exchange methods. Sood VK; Lee KS; Boulay SF; Rayeq MR; McRee RC; Cohen EI; Zeeberg BR; He XS; Weinberger DR; Rice K; Reba RC Appl Radiat Isot; 1997 Jan; 48(1):27-35. PubMed ID: 9022211 [TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport. Zimmerman TW; Binder HJ Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277 [TBL] [Abstract][Full Text] [Related]